[1]UCHIYAMA M, YAMAMOTO K, OCHIAI M, et al. Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan[J]. Biologicals, 2014, 42(2): 109-113.
[2]DING Y, ZHU D, ZHANG J, et al. Virulence determinants, antimicrobial susceptibility, and molecular profiles of Erysipelothrix rhusiopathiae strains isolated from China[J]. Emerg Microbes Infect, 2015, 4(11): e69.
[3]陆萍, 黄晓慧, 李春芬,等. 安徽部分地区猪丹毒杆菌的分离鉴定及生物学特性研究[J]. 微生物学通报, 2014, 41(9): 1822-1828.
LU P, HUANG X H, LI C F, et al. Isolation, identification and characterization of Erysipelothrix rhusiopathiae in Anhui province[J]. Microbiology China, 2014, 41(9): 1822-1828. (in Chinese)
[4]BENDER J S, SHEN H G, IRWIN C K, et al. Characterization of Erysipelothrix species isolates from clinically affected pigs, environmental samples, and vaccine strains from six recent swine erysipelas outbreaks in the United States[J]. Clin Vaccine Immunol, 2010,17(10): 1605-1611.
[5]IMADA Y, TAKASE A, KIKUMA R, et al. Serotyping of 800 strains of Erysipelothrix isolated from pigs affected with erysipelas and discrimination of attenuated live vaccine strain by genotyping[J]. J Clin Microbiol, 2004, 42(5): 2121-2126.
[6]EAMENS G J, FORBES W A, DJORDJEVIC S P. Characterization of Erysipelothrix rhusiopathiae isolates from pigs associated with vaccine breakdowns[J]. Vet Microbiol, 2006, 115(4): 329-338.
[7]OZAWA M, YAMAMOTO K, KOJIMA A, et al. Etiological and biological characteristics of Erysipelothrix rhusiopathiae isolated between 1994 and 2001 from pigs with swine erysipelas in Japan[J]. J Vet Med Sci, 2009, 71(6): 697-702.
[8]NEUMANN E J, GRINBERG A, BONISTALLI K N, et al. Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine[J]. Vet Microbiol, 2009, 135(3-4): 297-303.
[9]UCHIYAMA M, YAMAMOTO K, OCHIAI M, et al. Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan[J]. Biologicals, 2014, 42(2): 109-113.
[10]HOFFMANN C W, BILKEI G. Case study: Chronic erysipelas of the sow: a subclinical manifestation of reproductive problems[J]. Reprod Domest Anim, 2002, 37(2): 119-120.
[11]TO H, SATO H, TAZUMI A, et al. Characterization of Erysipelothrix rhusiopathiae strains isolated from recent swine erysipelas outbreaks in Japan[J]. J Vet Med Sci, 2012, 74(7): 949-953.
[12]卢琴, 李明波,彭先文,等. 猪丹毒杆菌spaA基因的生物信息学分析[J]. 动物医学进展, 2015, 36(9): 23-27.
LU Q, LI M B, PENG X W, et al. Bioinformatics analysis of spaA gene of Erysipelothrix rhuriopathiae[J]. Progress in Veterinary Medicine, 2015, 36(9): 23-27. (in Chinese)
[13]CHEUN H I, KAWAMOTO K, HIRAMATSU M, et al. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection[J]. J Appl Microbiol, 2004, 96(6): 1347-1353.
[14]MAKINO S, YAMAMOTO K, ASAKURA H, et al. Surface antigen, SpaA, of Erysipelothrix rhusiopathiae binds to Gram-positive bacterial cell surfaces[J]. FEMS Microbiol Lett, 2000, 186(2): 313-317.
[15]吾鲁木汗•那孜尔别克,张磊,何翠, 等. 猪丹毒丝菌天然SpaA和重组SpaA-N免疫保护效果的评价[J]. 微生物学报, 2010 , 50(3): 367-372.
NAZIERBIEKE W, ZHANG L, HE C, et al. Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice[J]. Acta Microbiologica Sinica, 2010 , 50(3): 367-372. (in Chinese)
[16]刘丹丹, 恩特马克•布拉提白, 杨振龙, 等. 红斑丹毒杆菌SpaA蛋白保护区域的免疫学检测[J]. 微生物学杂志, 2013, 33(5): 5-11.
LIU D D, ENTEMAKE B L T B, YANG Z L, et al. Immunological testing of protein protective domain SpaA of Erysipelothrix rhusiopathiae [J]. Journal of Microbiology, 2013, 33(5): 5-11.(in Chinese)
[17]HADAD R, MARKS E, KALBINA I,et al. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen[J]. APMIS, 2016, 124(12): 1078-1086.
[18]杨振龙. 红斑丹毒丝菌的致病性研究及其表面蛋白的MALDI-TOF质谱分析[D].吉首:吉首大学,2015.
YANG Z L. Characterization of Erysipelothrix rhusiopathiae pathogenicity and identification of surface protein though MALDI-TOF-MS analysis[D]. Jishou: Jishou University,2015.(in Chinese)
[19]LAMBKIN-WILLIAMS R, GELDER C, BROUGHTON R, et al. An intranasal proteosome-adjuvanted trivalent influenza vaccine is safe, immunogenic & efficacious in the human viral influenza challenge model. Serum IgG & mucosal IgA are important correlates of protection against illness associated with infection[J]. PLoS One, 2016, 11(12): e0163089.
[20]GIMÉNEZ-LIROLA L G, XIAO C T, HALBUR P G, et al. Development and evaluation of an enzyme-linked immunosorbent assay based on a recombinant SpaA protein (rSpaA415) for detection of anti-Erysipelothrix spp. IgG antibodies in pigs[J]. J Microbiol Methods, 2012, 91(1): 191-197.
[21]GALL-DEBRECENI A, LAZAR J, KADAS J, et al. Specific detection and quantitation of bovine IgG in bioreactor derived mouse mAb preparations[J]. J Immunol Methods, 2016, 438:26-34.
[22]BENDER J S, KINYON J M, KARIYAWASAM S, et al. Comparison of conventional direct and enrichment culture methods for Erysipelothrix spp. from experimentally and naturally infected swine[J]. J Vet Diagn Invest, 2009, 21(6): 863-868.
[23]陈宏. 巨噬细胞 PPARγ 对皮肤伤口愈合的作用研究[D]. 重庆:第三军医大学, 2015.
CHEN H. Macrophages PPARγ deficiency delays skin wound healing through impairing apoptotic cells clearance in mice[D]. Chongqing: Third Military Medical University, 2015.(in Chinese)
[24]朱良全,冯倩倩,李聪研,等.生产用培养基对猪丹毒丝菌G4T10株安全及免疫原性试验的比较研究[J]. 中国兽药杂志, 2013, 47(12): 22-24.
ZHU L Q, FENG Q Q, LI C Y, et al. Comparative study about the effect of culture media on the safety and immunogenicity of Erysipelothrix rhusiopathiae strain G4T10 [J]. Chinese Journal of Veterinary Drug, 2013, 47(12): 22-24. (in Chinese) |